By Ashley Braun-Gabelman, PhD, University Hospitals Case Medical Center
Prefer to watch the module? Click here. After viewing the module, go to the last slide in the PPT slides to access the post-test link.
Module Description: The number of women affected by opioid use disorder is rapidly increasing. Many estimate that women are more likely to abuse prescription opioids than men, and the percentage of women who abuse heroin has increased by 100% from 2002 – 2013. Important biopsychosocial gender differences exist which are important for risk factors for developing the disease, trajectory of the disease, and treatment planning, retention, and continued recovery. After completing this module, participants will be able to identify the changing demographics of heroin and opioid use disorders, discuss gender-related treatment issues including specific barriers to treatment for women and the impact of co-occurring disorders, and identify specific treatment concerns when treating pregnant women addicted to opioids.
View the 6/15/16 follow-up webinar recording and presentation slides here.
- Identify changing demographics of heroin and opioid use disorders
- Recognize barriers to treatment
- Discuss gender-related treatment issues
- Describe co-occurring disorders
- Identify treatment options for pregnant women
Accreditation and Designation: American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
System Requirements: Adobe Reader. To install for free, click here.